Volume 28, Issue. 5, October, 2012


Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease

 Xue-Mei Gu1, Han-Chang Huang2,3, Zhao-Feng Jiang2 


1Beijing Military General Hospital, Beijing 100700, China
2Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing 100191, China
3College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China

Abstract 

Alzheimer’s disease (AD) is an age-related neurodegenerative disorder. The pathology of AD includes amyloid-β (Aβ) deposits in neuritic plaques and neurofibrillary tangles composed of hyperphosphorylated tau, as well as neuronal loss in specific brain regions. Increasing epidemiological and functional neuroimaging evidence indicates that global and regional disruptions in brain metabolism are involved in the pathogenesis of this disease. Aβprecursor protein is cleaved to produce both extracellular and intracellular Aβ, accumulation of which might interfere with the homeostasis of cellular metabolism. Mitochondria are highly dynamic organelles that not only supply the main energy to the cell but also regulate apoptosis. Mitochondrial dysfunction might contribute to Aβ neurotoxicity. In this review, we summarize the pathways of Aβ generation and its potential neurotoxic effects on cellular metabolism and mitochondrial dysfunction.

Keywords

Alzheimer’s disease; amyloid-β; metabolic deficiency; mitochondrial dysfunction

[SpringerLink]